Clinical trial execution becomes governable when the underlying conditions have clear names, consistent definitions, and measurable consequences. These are the concepts Jumo Health uses to connect patient experience with completion.
Each term below describes an operational condition that can affect whether an eligible patient advances, participates, and completes. The definitions are concise by design and connect directly to the systems that assess, create, or govern readiness.
The degree to which a patient is cognitively, emotionally, practically, and contextually prepared to participate in and complete a clinical trial.
Readiness is dynamic. It can strengthen through education and support or deteriorate as burden, uncertainty, logistics, and caregiver conditions change.
Read more about readiness →An organization that connects behavioral science, health literacy, human-centered design, data intelligence, and execution around whether participation can hold.
A Patient Experience Organization creates operational ownership for readiness across recruitment, enrollment, retention, and completion.
Explore Jumo Health's PXO model →The gap between what a clinical trial requires a patient to understand and what the patient can realistically comprehend, retain, and use in a participation decision.
Cognitive friction can produce fragile consent, expectation mismatch, repetitive site education, and downstream withdrawal.
See the behavioral science →A structured view of the cognitive, emotional, practical, behavioral, social, and protocol-related barriers most likely to interrupt patient progression.
The map turns generalized engagement problems into specific barriers that can be addressed with appropriate education, support, or workflow intervention.
See how PRISM applies it →A study- or cohort-level view of the readiness conditions that influence activation, persistence, and completion.
The index provides a common operating signal for where completion risk may be concentrating before retrospective metrics reveal the consequence.
Explore readiness intelligence →An evidence-informed estimate of how likely a patient or cohort is to sustain participation through the final required trial milestone.
Completion probability extends beyond eligibility by considering the human and operational conditions that determine whether participation remains feasible over time.
Explore the PRISM architecture →